FWM
CRBU icon

FSA Wealth Management’s Caribou Biosciences CRBU Stock Holding History

FSA Wealth Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$20.1K Hold
8,630
– – 0.01% 252
2025
Q2 		$10.9K Hold
8,630
– – ﹤0.01% 282
2025
Q1 		$7.88K Buy
8,630
+1,950
+29% +$2.53K ﹤0.01% 301
2024
Q4 		$10.6K Buy
6,680
+1,900
+40% +$3.82K ﹤0.01% 293
2024
Q3 		$9.37K Buy
+4,780
New +$9.79K ﹤0.01% 316
2024
Q1 		$10.2K Buy
+1,980
New +$12.2K ﹤0.01% 325

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FSA Wealth Management's CRBU Position: Q3 2025 in Review

FSA Wealth Management held its Caribou Biosciences (CRBU) position steady in Q3 2025 at 8,630 shares worth $20.1K. The position accounts for 0.01% of the portfolio, ranked #252.

FSA Wealth Management first reported a position in CRBU in Q1 2024 and has held it in 6 quarters since. 117 funds tracked by Wall St. Rank hold CRBU as of Q3 2025.

  • FSA Wealth Management held 8,630 shares of Caribou Biosciences worth $20.1K as of Q3 2025.
  • FSA Wealth Management left its Caribou Biosciences share count unchanged in Q3 2025.
  • Caribou Biosciences made up 0.01% of FSA Wealth Management's portfolio in Q3 2025, its #252 holding.
  • FSA Wealth Management first reported a position in Caribou Biosciences in Q1 2024 and has held it in 6 quarters since.
  • 117 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.